Fingerprint
Dive into the research topics of 'Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results
Neal Shore, Steven A. Kaplan, Ronald Tutrone, Richard Levin, James Bailen, Alan Hay, Susan Kalota, Mohamed Bidair, Sheldon Freedman, Kenneth Goldberg, Frederick Snoy, Jonathan I. Epstein
Research output: Contribution to journal › Article › peer-review